Danaher Corporation (NYSE:DHR) Stock Holdings Increased by OVERSEA CHINESE BANKING Corp Ltd

OVERSEA CHINESE BANKING Corp Ltd grew its position in shares of Danaher Corporation (NYSE:DHR) by 3,673.5% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 38,037 shares of the conglomerate’s stock after purchasing an additional 37,029 shares during the quarter. OVERSEA CHINESE BANKING Corp Ltd’s holdings in Danaher were worth $7,812,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of the company. Fortis Capital Advisors LLC increased its position in shares of Danaher by 1.3% during the 4th quarter. Fortis Capital Advisors LLC now owns 3,983 shares of the conglomerate’s stock valued at $914,000 after purchasing an additional 50 shares during the period. Fayez Sarofim & Co increased its position in shares of Danaher by 0.6% during the 4th quarter. Fayez Sarofim & Co now owns 8,287 shares of the conglomerate’s stock valued at $1,902,000 after purchasing an additional 50 shares during the period. Coastal Bridge Advisors LLC increased its position in shares of Danaher by 4.8% during the 4th quarter. Coastal Bridge Advisors LLC now owns 1,099 shares of the conglomerate’s stock valued at $252,000 after purchasing an additional 50 shares during the period. Perennial Investment Advisors LLC increased its position in shares of Danaher by 2.2% during the 4th quarter. Perennial Investment Advisors LLC now owns 2,343 shares of the conglomerate’s stock valued at $538,000 after purchasing an additional 51 shares during the period. Finally, MGO One Seven LLC increased its position in shares of Danaher by 1.3% during the 4th quarter. MGO One Seven LLC now owns 4,285 shares of the conglomerate’s stock valued at $984,000 after purchasing an additional 53 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Danaher

In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of the business’s stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the sale, the chairman owned 3,105,808 shares of the company’s stock, valued at $611,036,665.92. The trade was a 28.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 11.10% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on DHR. Evercore ISI lowered their price target on Danaher from $230.00 to $226.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 8th. HSBC decreased their target price on Danaher from $270.00 to $240.00 in a report on Friday, April 25th. Bank of America decreased their target price on Danaher from $265.00 to $230.00 in a report on Monday, April 14th. Robert W. Baird lifted their target price on Danaher from $225.00 to $226.00 and gave the stock an “outperform” rating in a report on Friday, July 18th. Finally, The Goldman Sachs Group decreased their target price on Danaher from $260.00 to $240.00 and set a “neutral” rating on the stock in a report on Wednesday, April 23rd. Three analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $247.61.

Danaher Stock Performance

Shares of NYSE DHR opened at $197.08 on Friday. The business’s 50-day moving average price is $197.49 and its two-hundred day moving average price is $202.68. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. Danaher Corporation has a one year low of $171.00 and a one year high of $279.90. The company has a market capitalization of $141.12 billion, a P/E ratio of 41.93, a price-to-earnings-growth ratio of 2.74 and a beta of 0.73.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%. The firm had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter in the previous year, the company posted $1.72 earnings per share. The business’s quarterly revenue was up 3.4% compared to the same quarter last year. Analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, July 25th. Shareholders of record on Friday, June 27th were given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher’s dividend payout ratio is currently 27.23%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.